FDA Approves Tryptyr Eye Drops for Dry Eye Disease
2025-06-02
Tryptyr works by stimulating corneal sensory nerves to increase natural tear productionContinue Reading
FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body
2025-05-27
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and olderContinue Reading
E-Cigarettes Reinforce Nicotine Addiction, Study Says
2025-05-23
FRIDAY, May 23, 2025 (HealthDay News) — Pod-style e-cigarettes appear to be more addictive than nicotine gum, making it harder for vapers to kick the habit, a small-scale lab study has found. E-cigarettes reinforced nicotine addiction more than nicotine gum among young adults who regularly vape, results show. Specifically, theContinue Reading
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
2025-05-22
THURSDAY, May 22, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines. The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies toContinue Reading
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
2025-05-21
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapyContinue Reading
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
2025-05-21
WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall. The new framework, announced Tuesday, says adults 65 and older, and people with certain health conditions, canContinue Reading
FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups
2025-05-19
MONDAY, May 19, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax’s COVID-19 vaccine, but only for certain people. The vaccine is now approved for adults ages 65 and older, or for people ages 12 to 64 who have at least oneContinue Reading
Medicare Low-Income Drug Benefit Saves Lives, Study Says
2025-05-16
FRIDAY, May 16, 2025 (HealthDay News) — Low-income Medicare beneficiaries are more likely to die if they lose access to crucial medication coverage, a new study says. More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces their drug costs, researchers saidContinue Reading
Trump’s Surgeon General Pick Touts Psychedelics for Health
2025-05-15
THURSDAY, May 15, 2025 (HealthDay News) — President Donald Trump’s choice for U.S. surgeon general has raised eyebrows for promoting the use of psychedelic drugs, such as psilocybin, in a 2024 book and her personal newsletter. His choice for the post is wellness influencer Dr. Casey Means, who was recommendedContinue Reading
Alzheimer’s Drug Can Be Safely Administered In Memory Clinics, Study Says
2025-05-15
THURSDAY, May 15, 2025 (HealthDay News) — The 2023 approval of the first drug shown to slow the progression of Alzheimer’s disease came with no small amount of concern from skeptics. Lecanemab (Leqembi) modestly slows Alzheimer’s by helping the body flush out amyloid beta proteins associated with toxic plaques in theContinue Reading